PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.72
ESG score 90-95% of BTAI's 62.39. Bill Ackman would demand clear ESG improvement catalysts.
53.15
Environmental score 90-95% of BTAI's 56.76. Bill Ackman would demand clear environmental improvement catalysts.
60.22
Social score 80-90% of BTAI's 67.02. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
62.78
Similar governance score to BTAI's 63.40. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.